Paying users zone. Data is covered by .

  • Get to Allergan PLC for $13.99, or

  • get to whole website for at least 3 months from $49.99.

 

$13.99

Statement of Financial Position, Liabilities and Stockholders' Equity

Difficulty: Beginner

The statement of financial position provides creditors, investors, and analysts with information on company's resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company's assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Allergan PLC, Consolidated Statement of Financial Position, Liabilities and Stockholders' Equity

USD $ in thousands

 
Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014 Dec 31, 2013
Accrued third-party rebates
Contractual commitments, including amount due to Teva
Accrued payroll and related benefits
Accrued returns
Interest payable
Royalties payable
Accrued pharmaceutical fees
Accrued R&D expenditures
Accrued severance, retention and other shutdown costs
Litigation-related reserves and legal fees
Accrued non-provision taxes
Current portion of contingent consideration obligations
Accrued selling and marketing expenditures
Dividends payable
Other accrued expenses
Accrued expenses
Accounts payable
Accounts payable and accrued expenses
Income taxes payable
Current portion of long-term debt and capital leases
Deferred revenue
Current liabilities held for sale
Deferred tax liabilities
Current liabilities
Long-term debt and capital leases, excluding current portion
Acquisition related contingent consideration liabilities
Long-term pension and post retirement liability
Legacy Allergan deferred executive compensation
Long-term severance and restructuring liabilities
Deferred revenue
Product warranties
Long-term contractual obligations
Litigation-related reserves
Other long-term liabilities
Other long-term liabilities
Long-term liabilities held for sale
Other taxes payable
Deferred tax liabilities
Non current liabilities
Total liabilities
Preferred shares, $0.0001 par value per share
Ordinary shares; $0.0001 par value per share
Additional paid-in capital
Retained earnings (accumulated deficit)
Accumulated other comprehensive income (loss)
Treasury stock, at cost
Shareholders' equity
Noncontrolling interest
Total equity
Total liabilities and equity
Source: Allergan PLC, Annual Reports
Item Description The company
Accounts payable Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Allergan PLC's accounts payable declined from 2015 to 2016 but then increased from 2016 to 2017 not reaching 2015 level.
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Allergan PLC's current liabilities declined from 2015 to 2016 but then increased from 2016 to 2017 exceeding 2015 level.
Non current liabilities Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle. Allergan PLC's non current liabilities declined from 2015 to 2016 and from 2016 to 2017.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Allergan PLC's total liabilities declined from 2015 to 2016 and from 2016 to 2017.
Shareholders' equity Total of all Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). Allergan PLC's shareholders' equity declined from 2015 to 2016 and from 2016 to 2017.
Total equity Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. Allergan PLC's total equity declined from 2015 to 2016 and from 2016 to 2017.

Top